Download PDF

Other users also viewed these articles

Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle Caecilia Sukowati; Loraine Kay D. Cabral; Claudio Tiribelli;
Ann Hepatol. 2022;27:
Clinical treatment of cholangiocarcinoma: an updated comprehensive review Alessandra Elvevi; Alice Laffusa; Miki Scaravaglio; Roberta Elisa Rossi; Raffaella Longarini; Anna Maria Stagno; Laura Cristoferi; Antonio Ciaccio; Diego Luigi Cortinovis; Pietro Invernizzi; Sara Massironi;
Ann Hepatol. 2022;27:
Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma Stephen Lam Chan; Richard S. Finn; Julien Edeline; Sadahisa Ogasawara; Jennifer J. Knox; Bruno Daniele; Baek-Yeol Ryoo; Philippe Merle; Mohamed Bouattour; Ho-Yeong Lim; Yee Chao; Thomas Yau; Barbara Anne Haber; Usha Malhotra; Abby B. Siegel; Chih-Chin Liu; Masatoshi Kudo; Ann-Lii Cheng;
10.1016/j.aohep.2025.102169